Having trouble viewing this email? View in your browser.

12 March 2019

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.


ECCMID 2019 – Programme sneak peak

ECCMID is approaching soon in Amsterdam! Have a sneak peak at the ECCMID planning process with the Programme committee – Highlights from the last planning meeting in Madrid are available now online!

› Read more

ESCMID/EITaF Postgraduate course: Emerging infections for clinicians and the WHO Emerging Diseases Clinical Assessment and Response Network (EDCARN)

Don’t miss the upcoming ESCMID/EITaF  course on Emerging infections for clinicians in Florence, Italy, from 13-15 May 2019.

This course will also include a day of workshop by the WHO Emerging Diseases Clinical Assessment and Response Network (EDCARN), simulating responses to an outbreak situation. Attendance grant applications are closing this Friday (15 March)!

› Read more

Registration for ECCMID 2019

ECCMID is approaching soon in Amsterdam!

Registrations are available at a reduced rate for ESCMID members on the official website.

Make sure you use our official website to book your hotels to get the best rates.

› Read more

Hold the date for ESCMID Vaccines Conference 2019

The 5th ESCMID conference on vaccines will be held in Bilbao, Spain, from the 6-8 September, 2019. The theme of this edition of the conference is ‘Vaccines against respiratory infections: new insights and new vaccines’. Review the preliminary programme online, registration will be opening soon!

› Read more

ESCMID/ESPID Joint Syymposium at 37th Annual ESPID Meeting

Heading to The 37th annual meeting of the European Society for Paediatric Infectious Diseases in Ljubljana this May?

Don’t miss the ESCMID/ESPID joint symposium on novelties in diagnostic microbiology in Paediatrics, with former TAE president David Ong presenting on bedside diagnostic tests.

› Read more

CMI highlight: Individual and community-level risk factors for ESBL Enterobacteriaceae colonization identified by universal admission screening in London

Otter et al., evaluated risk factors for gastrointestinal carriage of ESBL-producing Enterobacteriaceae (ESBL-E) including individual-level variables such as antibiotic use and travel abroad as well as community variables such as housing and deprivation.

All admissions to a London hospital group were approached to be screened for ESBL-E carriage using rectal swabs for four months in 2015 in an observational study. Patients completed a risk factor questionnaire. Those with a residential postcode in the local catchment area were linked to a database containing community-level risk factor data. Risk factors for ESBL-E carriage were determined by binary logistic regression.
360 (9.0%) of 4006 patients carried ESBL-E. E.coli was the most common organism (77.8%), and CTX-M-type ESBLs the most common genes (57.9% CTX-M-15, and 20.7% CTX-M-9). In multivariable analysis, risk factors for phenotypic ESBL-E among the 1633 patients with a residential postcode within the local catchment area were travel to Asia (OR 4.4, CI 2.5-7.6), or Africa (OR 2.4, CI 1.2-4.8) in the 12 months prior to admission, two or more courses of antibiotics in the 6 months prior to admission (OR 2.0, CI 1.3-3.0), and residence in a district with a higher than average prevalence of overcrowded households (OR 1.5, CI 1.05-2.2).

Both individual and community variables were associated with ESBL-E carriage at hospital admission. The authors concluded that the new observation that household overcrowding is associated with the carriage of ESBL-ES needs to be confirmed, but raises the possibility that targeted interventions in the community may help prevent the transmission of antibiotic-resistant Gram-negative bacteria.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Phone +41 61 5080 173
Visit us on LinkedIn Visit us on YouTube
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.